Recombinant follistatin-FC fusion proteins and their use in the treatment of Duchenne muscular dystrophy

MA43588AUndetermined Publication Date: 2021-06-02TAKEDA PHARMA CO LTD

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA43588
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2016-03-04
Filing Date: 2017-03-03
Publication Date: 2021-06-02

Application Information

Patent Timeline

04 Mar 2016

Priority

03 Mar 2017

Application

MA43588

02 Jun 2021

Publication

MA43588A

IPC: A61K38/17; A61K38/22; A61P21/00; C07K14/47

CPC: A61K45/06; C07K14/4703; C07K14/4708; A61K38/00; A61K39/395; C07K2319/30; A61P21/00; A61P21/04

Inventors: ISKENDERIAN Andrea; NORTON Angela W.

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.